- Cash and cash equivalents were reported at $50.1 million, significantly below the estimate of $1.11 billion.
- Digital assets exceeded expectations, reaching $64.36 billion compared to the forecasted $48.96 billion.
- Revenue came in at $114.5 million, surpassing the estimate of $112.8 million.
- Product licenses and subscription services revenue stood at $48.0 million, higher than the projected $39.7 million.
- Product support revenue was $52.1 million, falling short of the $58.3 million estimate.
- Other services revenue reached $14.4 million, slightly under the anticipated $15.4 million.
- Gross profit was reported at $78.7 million, below the estimated $80.8 million.
- Research and development expenses were lower than expected, at $24.1 million versus the $27.7 million estimate.
- The company achieved a year-to-date BTC Yield of 25%, meeting the full year target ahead of schedule.
- Bitcoin per Share increased by 25% year-to-date, leading to raised BTC Yield and BTC $ Gain KPI targets of 30% and $20 billion, respectively.
- FY2025 guidance announced for Operating Income of $34 billion, Net Income of $24 billion, and Diluted EPS of $80 per share, based on a BTC price outlook of $150,000 by year-end.
- BTC $ Gain exceeded $13 billion, with a boost in Bitcoin pricing resulting in Q2 operating income of $14 billion and Q2 diluted EPS of $32.60.
- Analyst ratings included 16 buys, 1 hold, and 1 sell.
Microstrategy Inc Cl A on Smartkarma
Analyst Coverage of MicroStrategy Inc Cl A on Smartkarma
Independent analysts on Smartkarma have provided mixed sentiment regarding MicroStrategy Inc Cl A. Jim Chanos, from Odd Lots, highlighted concerns about companies like MicroStrategy inflating their value through Bitcoin holdings. In contrast, Baptista Research sees MicroStrategy increasing institutional adoption of Bitcoin to enhance financial metrics and investor confidence, emphasizing the company’s strategic focus on Bitcoin investments. Joe Jasper, also bullish, suggested a major low is likely in place on the S&P 500, impacting companies like MicroStrategy. Moreover, Baptista Research discussed MicroStrategy’s rebranding as Strategy and its commitment to digital assets and business intelligence amidst significant transformations. The discussions reflect varying perspectives on MicroStrategy’s strategies and performance in the market.
A look at Microstrategy Inc Cl A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Microstrategy Inc Cl A, a company providing business intelligence software and services, shows a promising long-term outlook based on Smartkarma Smart Scores. With a strong momentum score of 5 and high growth score of 4, the company is positioned for potential expansion and market performance. However, weaknesses in resilience and dividend scores may pose some risks and challenges for investors to consider. Overall, with a mixed bag of scores including solid growth and momentum but lower resilience and dividend outlook, Microstrategy Inc Cl A presents an interesting investment opportunity in the business intelligence sector.
Microstrategy Inc Cl A, specializing in business intelligence software for various industries such as retail, finance, and healthcare, receives varying scores across different factors according to Smartkarma Smart Scores. While the company demonstrates robust growth potential with a score of 4 in that category, it lags behind in areas such as resilience and dividends, receiving scores of 2 and 1, respectively. This suggests that while Microstrategy Inc Cl A may have exciting growth prospects, investors should be mindful of its lower resilience and dividend outlook when considering investment decisions in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
